The Federal Government through the National Agency for the Control of AIDS (NACA) and the Nigeria Centre for Disease Control (NCDC) has dismissed the claims by a Professor of Veterinary Medicine and Clinical Virology at the Michael Okpara University of Agriculture in Umudike, Abia State, Prof. Maduike Ezeibe, to have discovered a new drug for the cure of Human Immunodeficiency Virus (HIV)/Acquired Immune Deficiency Syndrome (AIDS).
According to a publication in the press, the professor said that the drug, produced with “Aluminum Magnesium Silicate” was tested on ten persons living with HIV and his tests reported a clinical outcome of an ability to “reach all cells” and making HIV “a conquered organism.”
Director-General of NACA, Dr. Sani Aliyu, and Chief Executive Officer of NCDC, Dr. Chikwe Ihekweazu, in a joint statement on Monday said there was no evidence from the press publication that the authors obtained ethical clearance from an appropriate body in Nigeria to conduct this study, and only ambiguous evidence that informed consent was sought from the evidently vulnerable patients.
According to them, there is really no basis for a claim to cure AIDS in this study and they are concerned that the publicity given to this claims will stop patients with HIV from taking life-saving anti-retroviral drugs (ARVs) and give them false hope of a cure.
The statement noted:
“It will be a great disservice to this vulnerable group of patients for the media to disseminate this claims in the absence of sound scientific evidence. There are long established, tried and tested routes for the discovery, development and validation of modern medicines before they can be registered and used for treatment in humans and animals.”
NACA and NCDC called on all academics to follow legal and scientifically acceptable methods in conducting their research and to avoid making premature claims capable of derailing the huge progress made in the last two decades on the war against HIV/AIDS.
According to both agencies, millions of lives have been saved as a result of modern anti-retroviral treatment and people living with HIV can now look forward to a normal healthy future. They, however, said they will continue to support the hard and diligent work being done by scientists in Nigerian universities and research institutions around the country. “We are always ready to partner with our scientists on all aspects of HIV research provided this is in line with international best practice,” they noted.
NACA and NCDC called on editors of media houses in Nigeria to seek comments from the leadership of relevant government parastatals and professional bodies when it receives new research findings related to their areas of responsibility.
“We assure you that we will respond rapidly and constructively to any queries. We also urge the editors of media houses in Nigeria to support their reporters to gain a deeper understanding of the complexities involved in the clinical trial process. In the run up to the next deadline, it is easy to fall into the trap of doing more harm than good, and the consequences of this can be deadly in the health sector. We will support the evolution of robust science journalism in Nigeria,” they noted.
They called on all patients living with HIV that are currently taking their medications to continue to do so and to see their doctors if they have any concern.
According to the statement, the NACA helpline (6222) is available on working days from 8am-8pm for the public seeking more information on HIV disease.